Analysis of the cause of increased measles incidence in Xinjiang, China in 2004

Pediatric Infectious Disease Journal

Volumn 26, Issue 6, 2007, Pages 513-518

  Yu, Xuelian ^a,b   Wang, Shaohua ^b   Guan, Jing ^b   Mahemuti, ^b   Purhati, ^b   Gou, Aili ^b   Liu, Quanming ^b   Jin, Xin ^b   Ghildyal, Reena ^a,c  

^a FUDAN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Measles virus; Seroprevalence; Xinjiang (China)

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; MEASLES VACCINE;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MORBIDITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SEROEPIDEMIOLOGY; SEROLOGY; SINGLE DRUG DOSE;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; DEMOGRAPHY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 34249776937     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31805ce299     Document Type: Article

References (28)

1. Ze WY. Expanded Program on Immunization. Shanghai: Shanghai Publishing House of Scientific and Technological Literature; 2001.
2. Wang LX, Zeng G, Lisa AL, et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis. 2003;187(Suppl 1):252-257.
3. Wang LX, Zhu X, Wang KA. Analysis of measles epidemiology in China in 2000. Chin J Vacc Immun. 2001;6:326-330.
4. Gou AL, Yu XL, Parti G, et al. Current state of measles epidemic in Xinjiang. Endemic Dis Bull. 2005;20:40-42.
5. WHO/UNICEF/GAVI/JICA/CDC. International Review of the Expanded Programme on Immunizations (EPI) in China. Geneva, Switzerland: WHO/UNICEF/GAVI/JICA/CDC; 2004.
6. China Ministry of Health. Plan for Acceleration of Measles Control in China. rfMOH Document. Report No. 16. Beijing: Ministry of Health; 1997.
7. China Ministry of Health. Plan for Measles Surveillance in China. rfMOH Document. Report No. 295. Beijing: Ministry of Health; 1998.
8. WHO. The Expanded Programme on Immunization Coverage Survey Manual. Report No. WHO/EPI/MLM/9. Geneva, Switzerland: World Health Organization; 1991.
9. WHO. Description and Comparison of the Methods of Cluster Sampling and Lot Quality Assurance Sampling to Assess Immunization Coverage. Report No. WHO/V&B/01.26. Geneva, Switzerland: World Health Organization; 2001.
10. Chantal EDV, Gerrit AVE, Marijke MK, Arno WH, Wim ABS, Niek JDW. Measles incidence estimations based on the notification by general practitioners were suboptimal. J Clin Epidemiol. 2004;57:633-637.
11. Ewert DP, Westman S, Frederick PD, Waterman SH. Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles. Public Health Rep. 1995;110:161-165.
12. Featherstone D, Brown D, Sanders R. Development of the global measles laboratory network. J Infect Dis. 2003;187(Suppl 1):S264-S269.
13. WHO. Global measles and rubella laboratory network-update. Wkly Epidemiol Rec. 2005;44:377-388.
14. Anderson MJ, Kidd IM, Morgan-Capner P. Human parvovirus and rubella-like illness. Lancet. 1985;2:663.
15. Davidkin I, Valle M, Peltola H, et al. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis. 1998:1567-1570.
16. Tait DR, Ward KN, Brown WG, Miller E. Exanthema subitum (roseola infantum) misdiagnosed in infants as measles or rubella. Br Med J. 1996;312:101-102.
17. Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis. 2003;187(Suppl 1):283-290.
18. Tischer A, Santibanez S, Siedler A, Heider A, Hengel H. Laboratory investigations are indispensable to monitor the progress of measles elimination - results of the German measles sentinel 1999-2003. J Clin Virol. 2004;31:165-178.
19. Silva JJ, Fernández MDP, Suárez M, Toledo M, Silva CA. Measles passive immunity in infants from vaccinated and disease acquired mothers. Pharmacoepidemiol Drug Saf. 1994;3:199-203.
20. Tapia MD, Sow SO, Medina-Moreno S, et al. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. Am J Trop Med Hyg. 2005;73:26-31.
21. Chiu HH, Lee CY, Chih TW, et al. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. J Med Virol. 1997;51:32-35.
22. Lee MS, Nokes DJ, Wu YC, Huang YH, Lu CF. Measles IgG seroprevalence prior to mass vaccination in Taiwan. Int J Infect Dis. 2002;6:42-47.
23. Li YB. Observation on the relationship between measles sera immunity of pregnant women and infant's measles infection rate in Zhejiang province. Infect Dis Inform. 2001;14:186-188.
24. Wang WP. Analysis on measles seraprevalence surveillance of pregnant women and infants in Guangdong province. Med J Chin People's Liberat. 2004;8:127.
25. Wu WT, Sun CM, Jiang MB, Zhang GH. Measles antibody surveillance on normal infants and pregnant women in Shanghai. Shanghai J Prevent Med. 2000;12:429-430.
26. Zhu Q, Li S, Ye XF, Ren G, zhou H, Du W. Analysis of current measles epidemic state in Guizhou, 1999-2001. Chin J Epidemiol. 2003;24:660.
27. Xu AQ, Feng ZJ, Xu WB, et al. Active case-based surveillance for measles in China: lessons learned from Shandong and Henan provinces. J Infect Dis. 2003;187(Suppl 1):258-263.
28. China Ministry of Health. Document on the Immunization Card Scheme. Report No. rfMOH/DDCdocument no. 73. Beijing: Ministry of Health/Department of Disease Control; 1984.